Comparison of Patients’ Diagnoses in a Dermatology Outpatient Clinic During the COVID-19 Pandemic Period and Pre-Pandemic Period

    December 2020 in “ International Journal of Clinical Practice ”
    Dursun Turkmen, Nihal Altunisik, Irem Mantar, Imge Durmaz, Serpil Sener, Cemil Colak
    Image of study
    TLDR The pandemic changed how often certain skin conditions were diagnosed.
    The study compared dermatological diagnoses at an outpatient clinic during a 3-month COVID-19 pandemic period with the same period in the previous year, involving 1286 patients during the pandemic and 1403 patients pre-pandemic. Findings showed a significant increase in urticaria, psoriasis, allergic/irritant contact dermatitis, scabies, lichen planus, mycosis fungoides, zona zoster, recurrent aphthous stomatitis, and polymorph light eruption, while there was a decrease in acne, other eczematous dermatitis, verruca, androgenic alopecia, and melanocytic nevus diagnoses during the pandemic. The study concluded that the pandemic affected the frequency of certain dermatological conditions seen in the clinic.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 3 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 3 months ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

      community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

      in Technology  15 upvotes 3 years ago
      The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.

    Similar Research

    5 / 1000+ results